Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study
- PMID: 38186903
- PMCID: PMC10768790
- DOI: 10.1093/ckj/sfad283
Risk factors for COVID-19 hospitalization and mortality in patients with chronic kidney disease: a nationwide cohort study
Abstract
Background: Several studies have demonstrated an increased risk of severe coronavirus disease 2019 (COVID-19) in chronic kidney disease (CKD) patients. However, few have investigated the impact of CKD stage and dialysis modality. The primary aim of this study was to investigate the association between CKD stage, dialysis modality and risk of severe COVID-19. Secondly, we aimed to study the impact of comorbidities and drugs on the risk of severe COVID-19 in the CKD population.
Methods: This nationwide observational study was based on data from the Swedish Renal Registry and three other national registries. Patients with non-dialysis CKD stage 3b-5 or dialysis on 1 January 2020 were included and followed until 31 December 2021. The primary outcome was COVID-19 hospitalization; the secondary outcome was COVID-19 mortality. Associations were investigated using logistic regression models, adjusting for confounders.
Results: The study population comprised 7856 non-dialysis CKD patients and 4018 dialysis patients. The adjusted odds ratios (aOR) for COVID-19 hospitalization and mortality were highest in the dialysis group [aOR 2.24, 95% confidence interval (CI) 1.79-2.81; aOR 3.10, Cl 95% 2.03-4.74], followed by CKD 4 (aOR 1.33, 95% CI 1.05-1.68; aOR 1.66, Cl 95% 1.07-2.57), as compared with CKD 3b. No difference in COVID-19 outcomes was observed between patients on hemodialysis and peritoneal dialysis. Overall comorbidity burden was one of the strongest risk factors for severe COVID-19 and the risk was also increased in patients prescribed insulin, proton pump inhibitors, diuretics, antiplatelets or immunosuppressants.
Conclusions: Worsening CKD stage and comorbidity are independent risk factors for severe COVID-19 in the Swedish CKD population.
Keywords: CKD; COVID-19; dialysis; mortality; risk factors.
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
Conflict of interest statement
No potential conflicts of interests relevant to this article were declared.
Figures


Similar articles
-
Nationwide in-hospital mortality and morbidity analysis of COVID-19 in advanced chronic kidney disease, dialysis and kidney transplant recipients.Front Med (Lausanne). 2023 Nov 2;10:1250631. doi: 10.3389/fmed.2023.1250631. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38020145 Free PMC article.
-
COVID-19 and chronic renal disease: clinical characteristics and prognosis.QJM. 2020 Nov 1;113(11):799-805. doi: 10.1093/qjmed/hcaa258. QJM. 2020. PMID: 32840579 Free PMC article.
-
Clinical outcomes among patients with chronic kidney disease hospitalized with diabetic foot disorders: A nationwide retrospective study.Endocrinol Diabetes Metab. 2021 Jun 9;4(3):e00277. doi: 10.1002/edm2.277. eCollection 2021 Jul. Endocrinol Diabetes Metab. 2021. PMID: 34277993 Free PMC article.
-
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis.Am J Kidney Dis. 2021 Dec;78(6):804-815. doi: 10.1053/j.ajkd.2021.07.003. Epub 2021 Aug 5. Am J Kidney Dis. 2021. PMID: 34364906 Free PMC article.
-
The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis.Kidney Blood Press Res. 2021;46(1):17-30. doi: 10.1159/000512211. Epub 2020 Dec 22. Kidney Blood Press Res. 2021. PMID: 33352576 Free PMC article.
Cited by
-
Impact of SARS-CoV-2 Infection on Erythropoietin Resistance Index in Hemodialysis Patients.Geriatrics (Basel). 2025 Feb 24;10(2):33. doi: 10.3390/geriatrics10020033. Geriatrics (Basel). 2025. PMID: 40126283 Free PMC article.
-
More severe comorbidities, advanced age, and incomplete vaccination increase the risk of COVID-19 mortality.Narra J. 2024 Aug;4(2):e949. doi: 10.52225/narra.v4i2.949. Epub 2024 Aug 14. Narra J. 2024. PMID: 39280314 Free PMC article.
-
Comorbidities and Severe COVID-19 Outcomes: A Retrospective Analysis of Hospitalized Patients in Three Counties in Romania.Microorganisms. 2025 Mar 29;13(4):787. doi: 10.3390/microorganisms13040787. Microorganisms. 2025. PMID: 40284624 Free PMC article.
-
Seroprevalence of SARS-CoV-2 antibodies in children with nephrotic syndrome and chronic kidney disease: a cross-sectional study from India.Pediatr Nephrol. 2025 Feb;40(2):441-447. doi: 10.1007/s00467-024-06534-y. Epub 2024 Sep 27. Pediatr Nephrol. 2025. PMID: 39327265
-
The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns.J Transl Med. 2024 Aug 16;22(1):773. doi: 10.1186/s12967-024-05578-w. J Transl Med. 2024. PMID: 39152439 Free PMC article.
References
-
- Sweden Public Health Agency . Several Signs of Social Spread of Covid-19 in Sweden. https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/m... (14 January 2023, date last accessed).
-
- Sweden Public Health Agency . Confirmed Case of the New Coronavirus in Jönköping. https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/j... (14 January 2023, date last accessed).
-
- Sweden Public Health Agency . Confirmed Cases of COVID-19 in Sweden 2022. https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuell... (14 January 2023, date last accessed).
-
- Sweden Public Health Agency . National Plan for Vaccination against Covid-19. https://www.folkhalsomyndigheten.se/publikationer-och-material/publikati... (14 January 2023, date last accessed).
LinkOut - more resources
Full Text Sources